We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$976M
1-Year Est. Return
66.76%
This Fund
S&P 500
This Quarter
Est. Return
+11.92%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$2.56B
AUM Growth
+$200M
(+8.5%)
Cap. Flow
-$91.6M
Cap. Flow
% of AUM
-3.58%
Top 10 Holdings %
Top 10 Hldgs %
35.03%
Holding
185
New
38
Increased
44
Reduced
32
Closed
58
Avg Time Held Equity + Options
2.5
quarters
Top 10 Avg Time Held Equity + Options
2
quarters
Top 20 Avg Time Held Equity + Options
1.6
quarters
Avg Time Held Equity only
2.8
quarters
Top 10 Avg Time Held Equity only
1.1
quarters
Top 20 Avg Time Held Equity only
1.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$34.8M |
| 2 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$31.9M |
| 3 |
eBay
EBAY
|
+$28.5M |
| 4 |
Yum! Brands
YUM
|
+$27.1M |
| 5 |
Hess
HES
|
+$22.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
+$29.6M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$23M |
| 3 |
Synovus
SNV
|
+$21.7M |
| 4 |
Bloomin' Brands
BLMN
|
+$21.2M |
| 5 |
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
|
+$20.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.33% |
| 2 | Healthcare | 20.81% |
| 3 | Consumer Discretionary | 10.85% |
| 4 | Technology | 9.69% |
| 5 | Consumer Staples | 5.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PUT
iShares Russell 2000 ETF
IWM
$77.9B
| $212M | 8.3% |
1,700,000
+185,000
| +12% | +$23.1M |
2014 Q3
3 quarters
|
|
|
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $116M | 4.52% |
3,325,829
-371,311
| -10% | -$11.3M |
2013 Q2
8 quarters
|
|
|
ANAC
3
CALL
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $104M | 4.07% |
1,345,700
+750,400
| +126% | +$49.2M |
2015 Q1
1 quarter
|
|
4
Tyson Foods
TSN
$18.9B
| $81.4M | 3.18% |
1,909,023
-205,865
| -10% | -$8.45M |
2014 Q2
4 quarters
|
|
5
Visteon
VC
$2.31B
| $77.1M | 3.02% |
734,659
+70,744
| +11% | +$7.45M |
2014 Q4
2 quarters
|
|
6
DELISTED
SUNEDISON, INC COM
SUNE
| $70.9M | 2.77% |
2,370,032
+457,866
| +24% | +$13M |
2014 Q3
3 quarters
|
|
7
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $61.8M | 2.41% |
300,000
-650,000
| -68% | -$137M |
2013 Q2
8 quarters
|
|
8
CALL
State Street Financial Select Sector SPDR ETF
XLF
$51B
| $61M | 2.38% |
+2,847,865
| New | +$61.5M |
2015 Q2
0 quarters
|
|
|
9
Adobe
ADBE
$92B
| $58M | 2.27% |
716,089
+445,629
| +165% | +$34.8M |
2015 Q1
1 quarter
|
|
|
CDK
10
DELISTED
CDK Global, Inc.
CDK
| $53.9M | 2.11% |
998,413
-175,298
| -15% | -$8.99M |
2014 Q4
2 quarters
|
|
11
PUT
iShares Biotechnology ETF
IBB
$10.2B
| $53.5M | 2.09% |
435,000
+60,000
| +16% | +$7.18M |
2014 Q4
2 quarters
|
|
12
CALL
Heron Therapeutics
HRTX
$74.2M
| $53M | 2.07% |
1,700,000
+1,300,000
| +325% | +$24.5M |
2015 Q1
1 quarter
|
|
|
AGN
13
DELISTED
Allergan plc
AGN
| $45.7M | 1.79% |
150,507
+51,678
| +52% | +$15.4M |
2013 Q3
7 quarters
|
|
14
Axalta
AXTA
$7.18B
| $39.1M | 1.53% |
1,180,861
+412,754
| +54% | +$13.6M |
2014 Q4
2 quarters
|
|
15
Armstrong World Industries
AWI
$6.96B
| $38.5M | 1.5% |
721,709
+277,013
| +62% | +$15.4M |
2015 Q1
1 quarter
|
|
16
DELISTED
Newfield Exploration
NFX
| $33.9M | 1.32% |
937,928
+329,073
| +54% | +$12.2M |
2015 Q1
1 quarter
|
|
|
AGN.PRA
17
DELISTED
Allergan plc
AGN.PRA
| $31.9M | 1.25% |
+30,500
| New | +$31.9M |
2015 Q2
0 quarters
|
|
|
HZNP
18
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $31.3M | 1.22% |
900,000
-350,000
| -28% | -$10.7M |
2014 Q3
3 quarters
|
|
|
ETFC
19
CALL
DELISTED
E*Trade Financial Corporation
ETFC
| $30.6M | 1.2% |
+1,020,600
| New | +$30M |
2015 Q2
0 quarters
|
|
20
HCA Healthcare
HCA
$99.8B
| $30.2M | 1.18% |
333,422
+191,206
| +134% | +$15.3M |
2013 Q2
8 quarters
|
|
|
21
eBay
EBAY
$51.8B
| $29M | 1.13% |
+1,143,433
| New | +$28.5M |
2015 Q2
0 quarters
|
|
22
Hilton Worldwide
HLT
$74.2B
| $28.3M | 1.11% |
342,440
+173,107
| +102% | +$15.2M |
2015 Q1
1 quarter
|
|
|
23
PUT
Tyson Foods
TSN
$18.9B
| $27.7M | 1.08% |
650,000
-250,000
| -28% | -$10.3M |
2015 Q1
1 quarter
|
|
|
24
Yum! Brands
YUM
$40.1B
| $27.7M | 1.08% |
+427,731
| New | +$27.1M |
2015 Q2
0 quarters
|
|
25
Vanda Pharmaceuticals
VNDA
$260M
| $27.2M | 1.06% |
2,141,835
+209,646
| +11% | +$2.26M |
2013 Q2
8 quarters
|
|
Similar funds
PHP
ACM
FM
PFGIA
PAMI
SI
ZI
RIA
Kingdon Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Kingdon Capital Management held 185 positions worth $2.56B, up 8.5% from $2.36B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Kingdon Capital Management withdrew a net $91.6M in Q2 2015, closing 58 positions and reducing 32 holdings. Its most notable exit was BROADCOM CORP CL-A, an estimated $23M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Kingdon Capital Management opened a new position in Allergan plc worth $31.9M.
- Kingdon Capital Management's largest Q2 2015 buy was Allergan plc: 30,500 shares worth $31.9M.
- Kingdon Capital Management added most to Adobe in Q2 2015, an estimated $34.8M increase.
- Kingdon Capital Management's biggest Q2 2015 reduction was ANACOR PHARMACEUTICALS INC COM, cutting an estimated $29.6M.
- Kingdon Capital Management fully exited BROADCOM CORP CL-A in Q2 2015, selling an estimated $23M.
- Kingdon Capital Management's ten largest holdings make up 35% of its $2.56B portfolio in Q2 2015.
- Kingdon Capital Management opened 38 new positions and closed 58 in Q2 2015.
- Kingdon Capital Management's portfolio value rose 8.5% quarter-over-quarter to $2.56B.
Based on Kingdon Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.